NCT06795022
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06795022
Title First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours (RHEA-1)
Acronym RHEA-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Research Site NOT_YET_RECRUITING La Jolla California 92093 United States Details
Research Site NOT_YET_RECRUITING Los Angeles California 90089 United States Details
Research Site NOT_YET_RECRUITING Baltimore Maryland 21201 United States Details
Research Site RECRUITING St Louis Missouri 63108 United States Details
Research Site NOT_YET_RECRUITING Hackensack New Jersey 07601 United States Details
Research Site RECRUITING Houston Texas 77030 United States Details
Research Site NOT_YET_RECRUITING Chengdu 610041 China Details
Research Site NOT_YET_RECRUITING Guangzhou 510515 China Details
Research Site NOT_YET_RECRUITING Harbin 150049 China Details
Research Site NOT_YET_RECRUITING Shanghai 201114 China Details
Research Site NOT_YET_RECRUITING Pokfulam 999077 Hong Kong Details
Research Site RECRUITING Shatin 000000 Hong Kong Details
Research Site RECRUITING Kashiwa 277-8577 Japan Details
Research Site RECRUITING Yokohama 241-8515 Japan Details
Research Site NOT_YET_RECRUITING Seoul 06351 South Korea Details
Research Site RECRUITING Seoul 5505 South Korea Details
Research Site NOT_YET_RECRUITING Barcelona 8035 Spain Details
Research Site NOT_YET_RECRUITING Pamplona 31008 Spain Details
Research Site RECRUITING Taipei 10002 Taiwan Details
Research Site RECRUITING Taoyuan District 333 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field